72 Biggest Movers From Yesterday
Gainers
Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share.
Why Gene Editing Stocks Are Trading Higher Again Today
Shares of gene editing stocks are continuing higher in sympathy with peer company Intellia (NASDAQ: NTLA), which gained in recent sessions following positive data for its investigational CRISPR therapy.
Editas Medicine Highlights Presentation Of Preclinical Data Supporting Initiation Of EDIT-301 Phase 1/2 RUBY Trial For Treatment Of Sickle Cell Disease At European Hematology Association Congress
Preclinical data demonstrated robust fetal hemoglobin (HbF) induction in erythroid progeny cells with no detection of off-target editing; cells showed reduced sickling and improved rheological behavior
RUBY trial of
Morgan Stanley Maintains Underweight on Editas Medicine, Lowers Price Target to $37
Morgan Stanley maintains Editas Medicine (NASDAQ:EDIT) with a Underweight and lowers the price target from $40 to $37.
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell
• Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.